首页 > 最新文献

Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi最新文献

英文 中文
Eicosanoids in asthma. 哮喘中的类二十烷酸。
Kong-Sang Wan, Wei-Fong Wu

Eicosanoids belong to a diverse family of bioactive fatty acids that play important roles in regulating airway inflammation and reactivity. They are the key mediators of the pathobiology of asthma. Among the eicosanoids, lipoxins (LXs) were the first agents to be identified and recognized as potential anti-inflammatory endogenous lipid mediators. Lipoxins are biosynthesized in vivo at inflammation sites. They result mainly from the interaction between 5 and 15-lipoxygenases (LOs), which are distinct from leukotrienes (LTs) and prostaglandins (PGs) in structure and function. Leukotrienes are potent proinflammatory mediators and directly and indirectly stimulate fibroblast chemotaxis, proliferation, and collagen synthesis. Prostaglandins have both bronchoconstrictive and bronchoprotective effects and the bronchoconstriction mediated by PGD2 and PGF2alpha is only occurred in asthmatic patients but not in healthy subjects. Lipoxins counter-regulate the proinflammatory actions of LTs and activate resolution of the inflammatory response. At least two classes of receptors, CysLT1 receptors and Asprin-triggered lipoxin A4 (ALX) receptors, can interact with lipoxin A4 (LXA4) and LXA4 analogs to mediate their biologic actions. Allergen challenge initiates airway biosynthesis of LXA4 and increases expression of its receptor. In addition, LXA4 affects the release of interleukin-8 by blood mononuclear cells, and ALX affects calcium influx into epithelial cells. Therefore, the pivotal role of LXs is mediating airway homeostasis, and LXs may be part of a novel, multipronged approach for treating human asthma.

类二十烷酸属于多种生物活性脂肪酸家族,在调节气道炎症和反应性方面发挥重要作用。它们是哮喘病理生物学的关键介质。在类二十烷类化合物中,脂毒素(lipoxins, LXs)是最早被发现并被认为是潜在的抗炎内源性脂质介质。脂毒素是在体内炎症部位生物合成的。它们主要是由5-和15-脂氧合酶(LOs)之间的相互作用引起的,它们在结构和功能上不同于白三烯(lt)和前列腺素(pg)。白三烯是有效的促炎介质,直接或间接刺激成纤维细胞趋化、增殖和胶原合成。前列腺素具有支气管收缩和支气管保护作用,PGD2和PGF2alpha介导的支气管收缩仅发生在哮喘患者中,而不发生在健康受试者中。脂质可以抑制LTs的促炎作用,并激活炎症反应的消退。至少有两类受体,CysLT1受体和阿司匹林触发的脂素A4 (ALX)受体,可以与脂素A4 (LXA4)和LXA4类似物相互作用,介导它们的生物作用。过敏原攻击启动气道LXA4的生物合成并增加其受体的表达。此外,LXA4影响血液单核细胞释放白细胞介素-8,ALX影响钙流入上皮细胞。因此,LXs的关键作用是调节气道内稳态,并且LXs可能是治疗人类哮喘的一种新的、多管齐下的方法的一部分。
{"title":"Eicosanoids in asthma.","authors":"Kong-Sang Wan,&nbsp;Wei-Fong Wu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Eicosanoids belong to a diverse family of bioactive fatty acids that play important roles in regulating airway inflammation and reactivity. They are the key mediators of the pathobiology of asthma. Among the eicosanoids, lipoxins (LXs) were the first agents to be identified and recognized as potential anti-inflammatory endogenous lipid mediators. Lipoxins are biosynthesized in vivo at inflammation sites. They result mainly from the interaction between 5 and 15-lipoxygenases (LOs), which are distinct from leukotrienes (LTs) and prostaglandins (PGs) in structure and function. Leukotrienes are potent proinflammatory mediators and directly and indirectly stimulate fibroblast chemotaxis, proliferation, and collagen synthesis. Prostaglandins have both bronchoconstrictive and bronchoprotective effects and the bronchoconstriction mediated by PGD2 and PGF2alpha is only occurred in asthmatic patients but not in healthy subjects. Lipoxins counter-regulate the proinflammatory actions of LTs and activate resolution of the inflammatory response. At least two classes of receptors, CysLT1 receptors and Asprin-triggered lipoxin A4 (ALX) receptors, can interact with lipoxin A4 (LXA4) and LXA4 analogs to mediate their biologic actions. Allergen challenge initiates airway biosynthesis of LXA4 and increases expression of its receptor. In addition, LXA4 affects the release of interleukin-8 by blood mononuclear cells, and ALX affects calcium influx into epithelial cells. Therefore, the pivotal role of LXs is mediating airway homeostasis, and LXs may be part of a novel, multipronged approach for treating human asthma.</p>","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27405679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrapleural streptokinase for the treatment of childhood empyema. 胸膜内注射链激酶治疗儿童脓胸。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0251
M. Ho, Hsiang-Yin Chen, Y. Yen, Yao-Shun Yang, S. Lien
BACKGROUNDPleuritis with empyema is a serious complication of bacterial pneumonia, which often causes substantial morbidity and mortality among pediatric patients. Currently percutaneous catheter drainage is the mainstay therapy for loculated empyema. Intrapleural instillation of streptokinase, urokinase, and recombinant tissue plasminogen activator has been reported to facilitate the drainage of viscous fluid and fibrinous debris or multiple loculations from the pleural space of such patients.METHODSIn this study, we compared with the treatments of pleural empyema by instillation of streptokinase through the chest tube and using the conventional chest tube drainage alone.RESULTSWe collected 21 cases from 1999 through 2005. The results of the study showed that streptokinase (SK) group patients revealed a larger volume of drainage in the beginning days of the instillation and required fewer days of drainage than tube drainage (T) group patients [8 (4.5 - 10) days vs. 16 (5.8 - 20.3) days, p = 0.02]; that the SK group patients required average 2.6 instillations. The SK patients had a shorter febrile course than the T group [12.5 (9.5 - 15.5) days vs. 16 (9.5 - 22.5) days, p = 0.14]. None of the SK patients needed additional video-assisted thoracoscopic surgery (VATS) whereas 5 patients in the T group did. The length of hospitalization in the SK group was 21.5 days and the T group patients was 24 days.CONCLUSIONSIntrapleural instillation of streptokinase seldom caused clinical adverse effect and appears to be a safe adjunctive therapy to facilitate the drainage of empyema in pediatric patients. Further studies with better research design to compare the fibrinolytic agent instillation and the VATS as the first step treatment of childhood empyema are needed.
背景胸膜炎并发脓胸是细菌性肺炎的严重并发症,在儿科患者中经常引起大量的发病率和死亡率。目前经皮置管引流是局部脓肿的主要治疗方法。据报道,胸膜内灌注链激酶、尿激酶和重组组织型纤溶酶原激活剂可促进此类患者胸腔内黏性液体和纤维质碎片或多发病灶的排出。方法比较经胸管滴注链激酶与常规胸管引流治疗胸膜脓肿的疗效。结果1999 ~ 2005年共收集21例病例。研究结果显示,链激酶(SK)组患者在滴注初期引流量较大,所需引流天数少于管引流(T)组患者[8(4.5 ~ 10)天比16(5.8 ~ 20.3)天,p = 0.02];SK组患者平均需要2.6次注射。SK组患者的发热病程较T组短[12.5(9.5 ~ 15.5)天比16(9.5 ~ 22.5)天,p = 0.14]。没有SK患者需要额外的视频辅助胸腔镜手术(VATS),而T组有5例患者需要。SK组患者住院时间21.5天,T组患者住院时间24天。结论胸膜内滴注链激酶很少引起临床不良反应,是一种安全的辅助治疗方法,可促进小儿脓胸的引流。需要进一步的研究,以更好的研究设计来比较纤溶剂滴注和VATS作为儿童脓胸的第一步治疗。
{"title":"Intrapleural streptokinase for the treatment of childhood empyema.","authors":"M. Ho, Hsiang-Yin Chen, Y. Yen, Yao-Shun Yang, S. Lien","doi":"10.7097/APT.200710.0251","DOIUrl":"https://doi.org/10.7097/APT.200710.0251","url":null,"abstract":"BACKGROUND\u0000Pleuritis with empyema is a serious complication of bacterial pneumonia, which often causes substantial morbidity and mortality among pediatric patients. Currently percutaneous catheter drainage is the mainstay therapy for loculated empyema. Intrapleural instillation of streptokinase, urokinase, and recombinant tissue plasminogen activator has been reported to facilitate the drainage of viscous fluid and fibrinous debris or multiple loculations from the pleural space of such patients.\u0000\u0000\u0000METHODS\u0000In this study, we compared with the treatments of pleural empyema by instillation of streptokinase through the chest tube and using the conventional chest tube drainage alone.\u0000\u0000\u0000RESULTS\u0000We collected 21 cases from 1999 through 2005. The results of the study showed that streptokinase (SK) group patients revealed a larger volume of drainage in the beginning days of the instillation and required fewer days of drainage than tube drainage (T) group patients [8 (4.5 - 10) days vs. 16 (5.8 - 20.3) days, p = 0.02]; that the SK group patients required average 2.6 instillations. The SK patients had a shorter febrile course than the T group [12.5 (9.5 - 15.5) days vs. 16 (9.5 - 22.5) days, p = 0.14]. None of the SK patients needed additional video-assisted thoracoscopic surgery (VATS) whereas 5 patients in the T group did. The length of hospitalization in the SK group was 21.5 days and the T group patients was 24 days.\u0000\u0000\u0000CONCLUSIONS\u0000Intrapleural instillation of streptokinase seldom caused clinical adverse effect and appears to be a safe adjunctive therapy to facilitate the drainage of empyema in pediatric patients. Further studies with better research design to compare the fibrinolytic agent instillation and the VATS as the first step treatment of childhood empyema are needed.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79781231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Trisomy 18 with multiple rare malformations: report of one case. 18三体合并多种罕见畸形1例报告。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0272
P. Su, Jia-yuh Chen, Chih-Hao Hsu, Suh-Jen Chen, Si-Wa Chan, Li-Ling Lin
Trisomy 18 syndrome is the second most common multiple malformation syndrome. The incidence is about 0.3 per 100 newborn babies. More than 130 different abnormalities have been noted in the literature on patients with the trisomy 18 syndrome. Trisomy 18 includes a broad spectrum of anomalies and malformations, among which we found Dandy-Walker malformation (DWM) rarely mentioned. DWM is estimated to occur in approximately 1 in 25,000 to 30,000 live births. The major components of DWM are the following: partial or complete absence of the cerebellar vermis, a posterior fossa cyst continuous with the fourth ventricle, and hydrocephalus. Although DWM has been associated with many chromosomal abnormalities and genetic syndromes in live birth, trisomy 18 with DWM is a rare condition. Here we present a female newborn with intrauterine growth retardation and multiple congenital abnormalities including: craniofacial anomaly, tracheoesophageal fistula, esophageal atresia, absent radius and thumb, short ulna, clenched hands, ventricular septal defect, coarctation of the aorta, patent ductus arteriosus, Meckel's diverticulum, ectopic pancreas in the ileum, and DWM. Her chromosome karyotype was 47,XX,+18. This is a case of Trisomy 18 with multiple rare malformations.
18三体综合征是第二常见的多发性畸形综合征。发病率约为每100名新生儿0.3例。在18三体综合征患者的文献中,有超过130种不同的异常。18三体包括广泛的异常和畸形,其中我们发现Dandy-Walker畸形(DWM)很少被提及。据估计,每2.5万至3万例活产婴儿中约有1例发生DWM。DWM的主要组成部分如下:小脑蚓部部分或完全缺失,连续第四脑室的后窝囊肿和脑积水。虽然DWM与许多染色体异常和活产遗传综合征有关,但18三体合并DWM是一种罕见的疾病。我们报告一例宫内发育迟缓的女性新生儿,伴有颅面畸形、气管食管瘘、食管闭锁、桡骨和拇指缺失、尺骨短、双手紧握、室间隔缺损、主动脉缩窄、动脉导管未闭、梅克尔憩室、回肠胰腺异位、DWM等多种先天性畸形。染色体核型分别为47、XX、+18。这是一例伴有多种罕见畸形的18三体。
{"title":"Trisomy 18 with multiple rare malformations: report of one case.","authors":"P. Su, Jia-yuh Chen, Chih-Hao Hsu, Suh-Jen Chen, Si-Wa Chan, Li-Ling Lin","doi":"10.7097/APT.200710.0272","DOIUrl":"https://doi.org/10.7097/APT.200710.0272","url":null,"abstract":"Trisomy 18 syndrome is the second most common multiple malformation syndrome. The incidence is about 0.3 per 100 newborn babies. More than 130 different abnormalities have been noted in the literature on patients with the trisomy 18 syndrome. Trisomy 18 includes a broad spectrum of anomalies and malformations, among which we found Dandy-Walker malformation (DWM) rarely mentioned. DWM is estimated to occur in approximately 1 in 25,000 to 30,000 live births. The major components of DWM are the following: partial or complete absence of the cerebellar vermis, a posterior fossa cyst continuous with the fourth ventricle, and hydrocephalus. Although DWM has been associated with many chromosomal abnormalities and genetic syndromes in live birth, trisomy 18 with DWM is a rare condition. Here we present a female newborn with intrauterine growth retardation and multiple congenital abnormalities including: craniofacial anomaly, tracheoesophageal fistula, esophageal atresia, absent radius and thumb, short ulna, clenched hands, ventricular septal defect, coarctation of the aorta, patent ductus arteriosus, Meckel's diverticulum, ectopic pancreas in the ileum, and DWM. Her chromosome karyotype was 47,XX,+18. This is a case of Trisomy 18 with multiple rare malformations.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87247516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency. 内皮功能障碍将心血管疾病与儿童慢性肾脏疾病联系起来:一氧化氮缺乏的作用
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0246
Y. Tain
Cardiovascular disease (CVD) is a major cause of death in pediatric patients with chronic kidney disease (CKD). Both types of traditional and CKD-related risk factors for CVD are prevalent in children with CKD. Many of these factors are associated with endothelial dysfunction (ED) and nitric oxide (NO) deficiency. ED with NO deficiency is both a cause and consequence of CKD. Hence, ED links CVD to pediatric CKD because ED plays a major role in the development of CVD. This review discusses how the risk factors for CVD contribute to ED and NO deficiency, leading to CVD in pediatric CKD. With early detection of ED by new non-invasive methods and restoration of NO bioavailability through different therapeutic approaches, the morbidity and mortality of CVD in pediatric CKD patients can be reduced.
心血管疾病(CVD)是儿童慢性肾脏疾病(CKD)患者死亡的主要原因。两种类型的传统和CKD相关的CVD危险因素在CKD儿童中普遍存在。许多这些因素与内皮功能障碍(ED)和一氧化氮(NO)缺乏有关。无缺陷ED既是CKD的原因,也是CKD的结果。因此,ED将CVD与儿童CKD联系起来,因为ED在CVD的发展中起着重要作用。这篇综述讨论了CVD的危险因素如何导致ED和NO缺乏,从而导致儿童CKD的CVD。通过新的无创方法早期发现ED,通过不同的治疗方法恢复NO的生物利用度,可以降低儿童CKD患者CVD的发病率和死亡率。
{"title":"Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.","authors":"Y. Tain","doi":"10.7097/APT.200710.0246","DOIUrl":"https://doi.org/10.7097/APT.200710.0246","url":null,"abstract":"Cardiovascular disease (CVD) is a major cause of death in pediatric patients with chronic kidney disease (CKD). Both types of traditional and CKD-related risk factors for CVD are prevalent in children with CKD. Many of these factors are associated with endothelial dysfunction (ED) and nitric oxide (NO) deficiency. ED with NO deficiency is both a cause and consequence of CKD. Hence, ED links CVD to pediatric CKD because ED plays a major role in the development of CVD. This review discusses how the risk factors for CVD contribute to ED and NO deficiency, leading to CVD in pediatric CKD. With early detection of ED by new non-invasive methods and restoration of NO bioavailability through different therapeutic approaches, the morbidity and mortality of CVD in pediatric CKD patients can be reduced.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86895180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial. 泼尼松龙口服溶液加普洛特罗吸入治疗儿童急性哮喘:一项双盲随机对照试验。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0257
Li-Hsin Huang, S. Shyur, D. Wen, Yi-Chi Chang, Yi-Chun Ma, Sheng-Chieh Lin, Wen-Chiu Wu, Jiunn-Yi Wu
BACKGROUNDTo evaluate the efficacy of prednisolone sodium phosphate oral solution plus inhaled procaterol in the treatment of acute asthma in children.METHODSForty-three patients aged 6 to 12 years with an acute exacerbation of asthma were double-blind randomized into one of two treatment groups in a 1:1 ratio:1) prednisolone oral solution +placebo tablets + procaterol MDI or 2) prednisolone tablets +placebo oral solution + procaterol MDI, all given three times daily for 7 days. Peak expiratory flow rate (PEFR), 24-hour reflective asthma symptom scores, spirometry and pulmonary index score (PIS) were recorded before and after treatment. Net changes in PEFR, symptom score, PIS, Forced Expiratory Volume in the first second (FEV1), FEV1/forced vital capacity (FVC), forced expiratory flow between 25 and 75 percent of the forced vital capacity (FEF(25-75%)) (before and after treatment) and global assessment by the investigator and the subjects or their parents were analyzed.RESULTSThe two groups were statistically similar at baseline values of these parameters. After a 7-day course of treatment, the net change of PEFR before and after treatment was significantly improved in both groups, but there was no significant difference in the net change of PEFR between the two groups (57.27+/-31.44 L/min vs. 54.29 +/-30.04 L/min, difference 2.99 +/-30.76 L/min, mean +/-SD, P=0.752). The net change in PIS and total symptom score did not differ between the two groups (P=0.091 and 0.827, respectively). Similarly, the FEV1, FEV1/FVC and FEF25-75% all improved with either treatment, and neither group was significantly superior to the other group (P=0.162, 0.48 and 0.081, respectively). Global assessment by the investigator and the subjects or their parents at the end of study indicated an essentially comparable result.CONCLUSIONSPrednisolone sodium phosphate oral solution plus inhaled procaterol is as efficacious as prednisolone tablets plus inhaled procaterol in the management of acute asthma in children.
目的:评价泼尼松龙磷酸钠口服溶液联合普洛特罗吸入治疗儿童急性哮喘的疗效。方法43例6 ~ 12岁哮喘急性加重患者,按1:1的比例随机分为2组:1)强的松龙口服液+安慰剂片+ procaterol MDI或2)强的松龙片+安慰剂口服液+ procaterol MDI,每日3次,连用7天。治疗前后记录呼气峰流速(PEFR)、24小时反射性哮喘症状评分、肺活量测定和肺指数评分(PIS)。分析PEFR、症状评分、PIS、第一秒用力呼气量(FEV1)、FEV1/用力肺活量(FVC)、用力呼气流量在用力肺活量(FEF(25-75%))的25%至75%之间(治疗前后)的净变化以及研究者和受试者或其父母的整体评估。结果两组在这些参数的基线值上具有统计学上的相似。治疗7 d后,两组患者治疗前后PEFR净变化均显著改善,但两组患者PEFR净变化无显著差异(57.27+/-31.44 L/min vs. 54.29 +/-30.04 L/min,差异2.99 +/-30.76 L/min,平均+/-SD, P=0.752)。两组患者PIS和总症状评分的净变化量无显著差异(P分别为0.091和0.827)。同样,FEV1、FEV1/FVC和FEF25-75%均改善,且两组均不显著优于另一组(P分别为0.162、0.48和0.081)。研究者和受试者或其父母在研究结束时进行的全面评估表明,结果基本相当。结论泼尼松龙磷酸钠口服液联合吸入普罗卡特罗治疗儿童急性哮喘的疗效与泼尼松龙片联合吸入普罗卡特罗相同。
{"title":"Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.","authors":"Li-Hsin Huang, S. Shyur, D. Wen, Yi-Chi Chang, Yi-Chun Ma, Sheng-Chieh Lin, Wen-Chiu Wu, Jiunn-Yi Wu","doi":"10.7097/APT.200710.0257","DOIUrl":"https://doi.org/10.7097/APT.200710.0257","url":null,"abstract":"BACKGROUND\u0000To evaluate the efficacy of prednisolone sodium phosphate oral solution plus inhaled procaterol in the treatment of acute asthma in children.\u0000\u0000\u0000METHODS\u0000Forty-three patients aged 6 to 12 years with an acute exacerbation of asthma were double-blind randomized into one of two treatment groups in a 1:1 ratio:1) prednisolone oral solution +placebo tablets + procaterol MDI or 2) prednisolone tablets +placebo oral solution + procaterol MDI, all given three times daily for 7 days. Peak expiratory flow rate (PEFR), 24-hour reflective asthma symptom scores, spirometry and pulmonary index score (PIS) were recorded before and after treatment. Net changes in PEFR, symptom score, PIS, Forced Expiratory Volume in the first second (FEV1), FEV1/forced vital capacity (FVC), forced expiratory flow between 25 and 75 percent of the forced vital capacity (FEF(25-75%)) (before and after treatment) and global assessment by the investigator and the subjects or their parents were analyzed.\u0000\u0000\u0000RESULTS\u0000The two groups were statistically similar at baseline values of these parameters. After a 7-day course of treatment, the net change of PEFR before and after treatment was significantly improved in both groups, but there was no significant difference in the net change of PEFR between the two groups (57.27+/-31.44 L/min vs. 54.29 +/-30.04 L/min, difference 2.99 +/-30.76 L/min, mean +/-SD, P=0.752). The net change in PIS and total symptom score did not differ between the two groups (P=0.091 and 0.827, respectively). Similarly, the FEV1, FEV1/FVC and FEF25-75% all improved with either treatment, and neither group was significantly superior to the other group (P=0.162, 0.48 and 0.081, respectively). Global assessment by the investigator and the subjects or their parents at the end of study indicated an essentially comparable result.\u0000\u0000\u0000CONCLUSIONS\u0000Prednisolone sodium phosphate oral solution plus inhaled procaterol is as efficacious as prednisolone tablets plus inhaled procaterol in the management of acute asthma in children.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91467471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Intussusception in children. 儿童肠套叠。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0243
Hung-Chang Lee
{"title":"Intussusception in children.","authors":"Hung-Chang Lee","doi":"10.7097/APT.200710.0243","DOIUrl":"https://doi.org/10.7097/APT.200710.0243","url":null,"abstract":"","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89131171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pheochromocytoma complicated with severe ventricular tachycardia: report of one case. 嗜铬细胞瘤合并严重室性心动过速1例报告。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0280
Yu-Chih Huang, Chao‐Hsiang Chang, C. Wang, Jeng‐Sheng Chang
Pheochromocytoma in children shows much worse complications than that in the adult patients. An 11-year-old girl was transferred to our emergency room after suffering from headache, dizziness, cold sweating and palpitation for 3 days. Severe hypertension, remarkable blood pressure fluctuation between 260/160 and 65/50 mmHg, decrease of cardiac contractility, as well as abnormal electrocardiogram findings including ST-T segment elevation and QT interval prolongation were noted soon after admission. Later, a 4x4.5x2.5 cm tumor in the right adrenal gland area was found by computed axial tomogram study. Assessment of the urine catecholamine metabolites showed high levels of vanillylmandelic acid, normetanephrine and norepinephrine indicating an active adrenal pheochromocytoma produced mainly norepinephrine. Although several antihypertensive drugs were used, ventricular tachycardia and Torsade de pointe still occurred on her for 3 times, each was preceded by a period of blood pressure fluctuation and burst out concomitantly at the peak of a hypertension crisis. From this case, we found that when the specific alpha-blocker like phenoxybenzamine or phentolamine was not available to us, labetalol by continuous intravenous infusion was the only effective drug to protect the patient from attacks of hypertensive crisis and ventricular tachycardia. Her right adrenal gland was resected smoothly when BP was well under control. Histological examination showed the adrenal medulla was full of pheochromocytoma cells.
儿童嗜铬细胞瘤的并发症比成人患者严重得多。一名11岁女童因头痛、头晕、冷汗、心悸3天入院。入院后不久即出现严重高血压,血压在260/160 ~ 65/50 mmHg之间波动明显,心脏收缩力下降,ST-T段抬高、QT间期延长等心电图异常。随后行计算机轴位断层扫描,发现右侧肾上腺区一4x4.5x2.5 cm肿瘤。尿液儿茶酚胺代谢物的评估显示高水平的香草扁桃酸,去甲肾上腺素和去甲肾上腺素表明一个活跃的肾上腺嗜铬细胞瘤主要产生去甲肾上腺素。虽然使用了几种降压药物,但仍发生3次室性心动过速和足尖扭转,每次发生前均有一段血压波动期,并在高血压危象的高峰时爆发。从这个病例中,我们发现当我们无法获得特异性的α -受体阻滞剂如苯氧苄胺或酚妥拉明时,持续静脉输注拉贝他洛尔是唯一有效的药物来保护患者免受高血压危象和室性心动过速的发作。在血压控制良好的情况下,顺利切除了右肾上腺。组织学检查显示肾上腺髓质充满嗜铬细胞瘤细胞。
{"title":"Pheochromocytoma complicated with severe ventricular tachycardia: report of one case.","authors":"Yu-Chih Huang, Chao‐Hsiang Chang, C. Wang, Jeng‐Sheng Chang","doi":"10.7097/APT.200710.0280","DOIUrl":"https://doi.org/10.7097/APT.200710.0280","url":null,"abstract":"Pheochromocytoma in children shows much worse complications than that in the adult patients. An 11-year-old girl was transferred to our emergency room after suffering from headache, dizziness, cold sweating and palpitation for 3 days. Severe hypertension, remarkable blood pressure fluctuation between 260/160 and 65/50 mmHg, decrease of cardiac contractility, as well as abnormal electrocardiogram findings including ST-T segment elevation and QT interval prolongation were noted soon after admission. Later, a 4x4.5x2.5 cm tumor in the right adrenal gland area was found by computed axial tomogram study. Assessment of the urine catecholamine metabolites showed high levels of vanillylmandelic acid, normetanephrine and norepinephrine indicating an active adrenal pheochromocytoma produced mainly norepinephrine. Although several antihypertensive drugs were used, ventricular tachycardia and Torsade de pointe still occurred on her for 3 times, each was preceded by a period of blood pressure fluctuation and burst out concomitantly at the peak of a hypertension crisis. From this case, we found that when the specific alpha-blocker like phenoxybenzamine or phentolamine was not available to us, labetalol by continuous intravenous infusion was the only effective drug to protect the patient from attacks of hypertensive crisis and ventricular tachycardia. Her right adrenal gland was resected smoothly when BP was well under control. Histological examination showed the adrenal medulla was full of pheochromocytoma cells.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87516532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura. 幽门螺杆菌感染与儿童特发性血小板减少性紫癜。
Pub Date : 2007-10-01 DOI: 10.7097/APT.200710.0263
Kuan-Sheng Wu, C. Hsiao, Hong-Ren Yu, E. Huang, Wanqi Mai, J. Sheen
BACKGROUNDSeveral studies showed some chronic idiopathic thrombocytopenic purpura (ITP) patients with complete platelet recovery after Helicobacter pylori (H. pylori) eradication and cited the cause of persistent thrombocytopenia as inability to eradicate H. pylori. So we studied H. pylori infection status in pediatric ITP patients at diagnosis and address whether such infection played a role in the development of childhood ITP.METHODSWe compared H. pylori infection status by stool H. pylori antigen test of an ITP group including 32 childhood ITP patients at diagnosis from September 2004 to June 2006 and a control group including 30 unselected patients with no history of thrombocytopenia seen consecutively with clinical manifestations of pharyngotonsillitis, bronchitis, or bronchopneumonia in our ward during a one-month span. We further analyzed parameters between H. pylori infection-positive (H. pylori(+)) and H. pylori infection-negative (H. pylori(-)) childhood ITP patients.RESULTSThe H. pylori-positive (H. pylori(+)) rate was 19% in the study group and 17% in the control group, with not statistically significant difference. As for the characteristics and treatment response about H. pylori status, they were also not statistically different. Although the ratio of chronic ITP cases showed higher tendency in H. pylori(+) patients (2/6) than the H. pylori(-) ones (3/26), it was not statistically significant.CONCLUSIONSIt seems that H. pylori infection played a minor role in the development of childhood ITP in this small-scale study. A large-scale study is necessary to further confirm the relationship between H. pylori infection and the development of childhood ITP.
几项研究显示,一些慢性特发性血小板减少性紫癜(ITP)患者在根除幽门螺杆菌(h.p ylori)后血小板完全恢复,并将持续血小板减少症的原因归结为无法根除幽门螺杆菌。因此,我们研究了儿童ITP患者诊断时的幽门螺杆菌感染情况,并探讨幽门螺杆菌感染是否在儿童ITP的发展中起作用。方法比较2004年9月至2006年6月诊断为ITP的32例儿童ITP患者与30例未选择的无血小板减少史的对照组在一个月内连续出现咽扁桃体炎、支气管炎或支气管肺炎的临床表现,通过粪便幽门螺杆菌抗原检测比较其感染情况。我们进一步分析了幽门螺杆菌感染阳性(H. pylori(+))和幽门螺杆菌感染阴性(H. pylori(-))儿童ITP患者之间的参数。结果研究组幽门螺杆菌阳性(H. pylori +)率为19%,对照组为17%,差异无统计学意义。在幽门螺杆菌状态的特点及治疗反应方面,两组间也无统计学差异。虽然幽门螺杆菌阳性组(2/6)比幽门螺杆菌阴性组(3/26)倾向于慢性ITP,但差异无统计学意义。结论本研究认为幽门螺杆菌感染在儿童ITP的发展中起次要作用。为了进一步证实幽门螺杆菌感染与儿童ITP发展之间的关系,需要进行大规模的研究。
{"title":"Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura.","authors":"Kuan-Sheng Wu, C. Hsiao, Hong-Ren Yu, E. Huang, Wanqi Mai, J. Sheen","doi":"10.7097/APT.200710.0263","DOIUrl":"https://doi.org/10.7097/APT.200710.0263","url":null,"abstract":"BACKGROUND\u0000Several studies showed some chronic idiopathic thrombocytopenic purpura (ITP) patients with complete platelet recovery after Helicobacter pylori (H. pylori) eradication and cited the cause of persistent thrombocytopenia as inability to eradicate H. pylori. So we studied H. pylori infection status in pediatric ITP patients at diagnosis and address whether such infection played a role in the development of childhood ITP.\u0000\u0000\u0000METHODS\u0000We compared H. pylori infection status by stool H. pylori antigen test of an ITP group including 32 childhood ITP patients at diagnosis from September 2004 to June 2006 and a control group including 30 unselected patients with no history of thrombocytopenia seen consecutively with clinical manifestations of pharyngotonsillitis, bronchitis, or bronchopneumonia in our ward during a one-month span. We further analyzed parameters between H. pylori infection-positive (H. pylori(+)) and H. pylori infection-negative (H. pylori(-)) childhood ITP patients.\u0000\u0000\u0000RESULTS\u0000The H. pylori-positive (H. pylori(+)) rate was 19% in the study group and 17% in the control group, with not statistically significant difference. As for the characteristics and treatment response about H. pylori status, they were also not statistically different. Although the ratio of chronic ITP cases showed higher tendency in H. pylori(+) patients (2/6) than the H. pylori(-) ones (3/26), it was not statistically significant.\u0000\u0000\u0000CONCLUSIONS\u0000It seems that H. pylori infection played a minor role in the development of childhood ITP in this small-scale study. A large-scale study is necessary to further confirm the relationship between H. pylori infection and the development of childhood ITP.","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83155895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Trisomy 18 with multiple rare malformations: report of one case. 18三体合并多种罕见畸形1例报告。
Pen-Hua Su, Jia-Yuh Chen, Chih-Hao Hsu, Suh-Jen Chen, Si-Wa Chan, Li-Ling Lin

Trisomy 18 syndrome is the second most common multiple malformation syndrome. The incidence is about 0.3 per 100 newborn babies. More than 130 different abnormalities have been noted in the literature on patients with the trisomy 18 syndrome. Trisomy 18 includes a broad spectrum of anomalies and malformations, among which we found Dandy-Walker malformation (DWM) rarely mentioned. DWM is estimated to occur in approximately 1 in 25,000 to 30,000 live births. The major components of DWM are the following: partial or complete absence of the cerebellar vermis, a posterior fossa cyst continuous with the fourth ventricle, and hydrocephalus. Although DWM has been associated with many chromosomal abnormalities and genetic syndromes in live birth, trisomy 18 with DWM is a rare condition. Here we present a female newborn with intrauterine growth retardation and multiple congenital abnormalities including: craniofacial anomaly, tracheoesophageal fistula, esophageal atresia, absent radius and thumb, short ulna, clenched hands, ventricular septal defect, coarctation of the aorta, patent ductus arteriosus, Meckel's diverticulum, ectopic pancreas in the ileum, and DWM. Her chromosome karyotype was 47,XX,+18. This is a case of Trisomy 18 with multiple rare malformations.

18三体综合征是第二常见的多发性畸形综合征。发病率约为每100名新生儿0.3例。在18三体综合征患者的文献中,有超过130种不同的异常。18三体包括广泛的异常和畸形,其中我们发现Dandy-Walker畸形(DWM)很少被提及。据估计,每2.5万至3万例活产婴儿中约有1例发生DWM。DWM的主要组成部分如下:小脑蚓部部分或完全缺失,连续第四脑室的后窝囊肿和脑积水。虽然DWM与许多染色体异常和活产遗传综合征有关,但18三体合并DWM是一种罕见的疾病。我们报告一例宫内发育迟缓的女性新生儿,伴有颅面畸形、气管食管瘘、食管闭锁、桡骨和拇指缺失、尺骨短、双手紧握、室间隔缺损、主动脉缩窄、动脉导管未闭、梅克尔憩室、回肠胰腺异位、DWM等多种先天性畸形。染色体核型分别为47、XX、+18。这是一例伴有多种罕见畸形的18三体。
{"title":"Trisomy 18 with multiple rare malformations: report of one case.","authors":"Pen-Hua Su,&nbsp;Jia-Yuh Chen,&nbsp;Chih-Hao Hsu,&nbsp;Suh-Jen Chen,&nbsp;Si-Wa Chan,&nbsp;Li-Ling Lin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Trisomy 18 syndrome is the second most common multiple malformation syndrome. The incidence is about 0.3 per 100 newborn babies. More than 130 different abnormalities have been noted in the literature on patients with the trisomy 18 syndrome. Trisomy 18 includes a broad spectrum of anomalies and malformations, among which we found Dandy-Walker malformation (DWM) rarely mentioned. DWM is estimated to occur in approximately 1 in 25,000 to 30,000 live births. The major components of DWM are the following: partial or complete absence of the cerebellar vermis, a posterior fossa cyst continuous with the fourth ventricle, and hydrocephalus. Although DWM has been associated with many chromosomal abnormalities and genetic syndromes in live birth, trisomy 18 with DWM is a rare condition. Here we present a female newborn with intrauterine growth retardation and multiple congenital abnormalities including: craniofacial anomaly, tracheoesophageal fistula, esophageal atresia, absent radius and thumb, short ulna, clenched hands, ventricular septal defect, coarctation of the aorta, patent ductus arteriosus, Meckel's diverticulum, ectopic pancreas in the ileum, and DWM. Her chromosome karyotype was 47,XX,+18. This is a case of Trisomy 18 with multiple rare malformations.</p>","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27247773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter therapy of Budd-Chiari syndrome in a child after liver transplantation: report of one case. 经导管治疗儿童肝移植术后Budd-Chiari综合征1例报告。
Chi-Lin Ho, Yun-Ching Fu, Chieh-Chung Lin, Shao-Bin Cheng, Sheng-Ling Jan, Ming-Chih Lin, Ching-Shiang Chi, Betau Hwang

Budd-Chiari syndrome is a rare, heterogenous and potentially lethal condition due to hepatic venous outflow obstruction. Classic triads include hepatomegaly, ascites and abdominal pain. Most cases are caused by abnormal coagulopathy, infection, inflammation or tumor invasion. Status post liver transplantation was rarely mentioned in the pediatric group. Here we report a case of 4-year-old girl with biliary atresia status post living donor liver transplantation. Marked ascites developed 2 months later and Budd-Chiari syndrome was diagnosed. Cardiac catheterization showed significant stenoses of the hepatic vein and inferior vena cava. Initial balloon angioplasty of inferior vena cava only resulted in mild improvement. After successful balloon angioplasty of the hepatic vein stenosis, the stenosis of the inferior vena cava improved significantly. The ascites resolved soon, and no more happened up to 8 months' follow-up.

Budd-Chiari综合征是一种罕见的,异质性和潜在的致命疾病,由肝静脉流出梗阻引起。典型的三联征包括肝肿大、腹水和腹痛。大多数病例是由凝血功能异常、感染、炎症或肿瘤侵袭引起的。肝移植后的状态在儿科组中很少被提及。我们在此报告一例4岁女童在活体肝移植后出现胆道闭锁的情况。2个月后出现明显腹水,诊断为Budd-Chiari综合征。心导管检查显示肝静脉及下腔静脉明显狭窄。最初的下腔静脉球囊成形术只导致轻微的改善。肝静脉球囊成形术成功后,下腔静脉狭窄明显改善。腹水很快消失,随访8个月无再次发生。
{"title":"Transcatheter therapy of Budd-Chiari syndrome in a child after liver transplantation: report of one case.","authors":"Chi-Lin Ho,&nbsp;Yun-Ching Fu,&nbsp;Chieh-Chung Lin,&nbsp;Shao-Bin Cheng,&nbsp;Sheng-Ling Jan,&nbsp;Ming-Chih Lin,&nbsp;Ching-Shiang Chi,&nbsp;Betau Hwang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Budd-Chiari syndrome is a rare, heterogenous and potentially lethal condition due to hepatic venous outflow obstruction. Classic triads include hepatomegaly, ascites and abdominal pain. Most cases are caused by abnormal coagulopathy, infection, inflammation or tumor invasion. Status post liver transplantation was rarely mentioned in the pediatric group. Here we report a case of 4-year-old girl with biliary atresia status post living donor liver transplantation. Marked ascites developed 2 months later and Budd-Chiari syndrome was diagnosed. Cardiac catheterization showed significant stenoses of the hepatic vein and inferior vena cava. Initial balloon angioplasty of inferior vena cava only resulted in mild improvement. After successful balloon angioplasty of the hepatic vein stenosis, the stenosis of the inferior vena cava improved significantly. The ascites resolved soon, and no more happened up to 8 months' follow-up.</p>","PeriodicalId":7156,"journal":{"name":"Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27247774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1